You are willing to pay for the prescription. The question is why pay a membership on top of it, month after month, for something no one has defined. We will answer that objection the way we wish someone had answered ours, plainly and with the price on the table.
- The membership and the medication are two separate charges. Only one of them goes to us.
- The prescription alone treats the symptom nobody has diagnosed. That is why plateaus and dose climbs keep happening.
- The $299 a month buys the clinician relationship and four lab panels a year at a price that never rises with your dose.
- We earn nothing on what you are prescribed, so our advice has no financial stake in the answer.
The visit you have already had
The prescription is easy to get in 2026. A form, a video call that lasts minutes and a vial arrives at your door. If you have been through it, you know what the next part looks like too. The dose goes up and the price goes up with it. When the scale stops moving, nobody orders a lab to find out why. You are paying every month for refills rather than for someone to know you.
We are not going to pretend that model has no value. It is fast and it is cheap at the start. The trouble begins the first time something changes. A side effect you did not expect, a plateau nobody explains or a bill that grows with every titration. At that moment the cheap prescription has no one behind it. You are alone with a drug and a symptom and the person who signed the script has already moved to the next form.
If that describes your last six months, it was never a discipline problem and it was never a dosing mystery. It was the predictable outcome of a system that gets paid for the prescription and paid nothing for the thinking. Our Cardiometabolic Optimization Membership exists because we wanted the opposite arrangement. You pay the clinician to know you and you pay the pharmacy for the drug and never let one payment depend on the other.
What the membership actually is
One flat $299 a month. A $598 hold covering your first two months is placed on your card at sign-up and is charged only once a clinician accepts you. If a clinician cannot accept you, the hold is released and you are never charged. Nothing about the fee changes with your prescription, because the fee has nothing to do with your prescription. It buys:
- A clinician licensed in your state who reviews your history and follows your results over time.
- A comprehensive Biomarker Audit every 90 days covering Hs-CRP, Lipoprotein (A), Hemoglobin A1c (HbA1c), Apolipoprotein B (ApoB), Fasting Insulin, TSH With Reflex To Free T4 and more.
- Every result in your hands, explained to you rather than filed away.
- Asynchronous messaging with the care team and video visits when you want them.
The medication is a separate matter entirely. When a drug is clinically indicated, your clinician prescribes it to the pharmacy you choose and the pharmacy bills you at its own price. GoodLife Health sets nothing on that transaction, sees nothing and takes nothing from it. There is no molecule upcharge and no dose upcharge, because there is no margin in it for us at any dose. The two-month start is a commitment we ask for because the first Biomarker Audit and the first protocol take that long to matter. After month two the membership is month to month and you can cancel anytime.
We call this arrangement Medication-Neutral Pricing and the point of the name is honesty about incentives. A practice that profits when your dose climbs has a reason to let it climb. We have no such reason in either direction. If the lowest effective dose gives you the result, that is the outcome we are paid to want, because our fee is the same either way.
Why the prescription alone has not worked
Here is the part the $99 apps and the dose-mill practices never say out loud. A GLP-1 prescription is a treatment for a condition that has causes and those causes differ from person to person. Insulin resistance, thyroid function, hormonal changes, sleep and the medications you already take all shape what the drug can do. When nobody measures them, the prescribing is guesswork with good marketing.
In our definitive guide to Cardiometabolic Optimization we walk through the markers that make treatment decisions different. The short version is that the same drug, prescribed to two people with the same weight, can produce very different results depending on what their labs were hiding. That is why the membership leads with the Biomarker Audit and lets the medication follow the evidence.
It is also why we prescribe branded, FDA-approved medication only. The FDA has been explicit that compounded copies do not undergo its premarket review for safety, quality or effectiveness and the agency has received reports of dosing errors and adverse events tied to them. We will not put a patient in that position to win a price comparison.
You may be reading this on tirzepatide today, paying a monthly fee that went up when your dose did. The question worth asking your current provider is simple. What would you do if my dose needed to come down? If the answer involves your monthly bill coming down too, you are in a rare arrangement. If the question makes no sense to them, you have found the problem the membership solves.
What the quarterly panel catches
The reason a membership can outperform a prescription is that the panel sees what the scale cannot. A fasting insulin that has been creeping for two years explains a plateau that no dose increase will fix. A thyroid result sitting at the top of the normal range explains fatigue that a stronger GLP-1 will not touch. An ApoB that has been rising quietly is a cardiovascular question that deserves its own plan, not a footnote in a weight-loss chat.
The comprehensive Biomarker Audit covers Hs-CRP, Lipoprotein (A), Hemoglobin A1c (HbA1c), Apolipoprotein B (ApoB), Fasting Insulin, TSH With Reflex To Free T4 and more. It repeats every 90 days, four times a year and the same clinician who ordered it explains it to you. When a trend emerges, the protocol changes because of evidence rather than because the subscription renewed. When nothing needs to change, we say that too and the dose stays where it is.
That last sentence matters more than it looks. In the dose-mill model, the answer to every stall is more drug, because more drug is the only thing the model knows how to sell. In the membership model, the answer to every stall is a measurement. Sometimes the measurement says the dose should come down. Our fee does not move either way, which is the only reason you can trust the answer.
What $299 a month is against
Numbers help here, so we will use the ones manufacturers published in September 2026. Through NovoCare, Wegovy pens are $199 a month for the first two fills and $349 a month after, with the Wegovy pill from $149 a month at lower doses. Through LillyDirect, Zepbound vials run $299 to $449 a month depending on dose. Those are pharmacy-side costs, charged to you by the pharmacy and they are the same for us as for anyone else.
What we remove is everything layered on top. The program fee that rises with titration, the membership tier that gates the stronger dose and the margin hiding in the vial. So the honest arithmetic of year one with us is $3,588 for the clinical relationship and the four panels, plus the pharmacy's own price for whatever you are prescribed. Compare that total against any alternative's total, dated and the structure of the deal becomes visible. Most alternatives quote you the drug and hide the practice. We quote you the practice and let the pharmacy charge you for the drug.
The trial evidence supports the measured approach. A review of the tirzepatide trials from the SURPASS program records how much these medications can achieve when they are used well. Used well is the operative phrase. The drug is not the product. The judgment about whether it is working, at what dose and against what measured baseline is the product and that judgment is what your $299 employs.
Who this is not for
Some readers should stop here and we would rather say so. If you want a prescription today with no labs and no history, the membership will feel slow. If you are looking for the cheapest possible vial and nothing else, you do not need us and a price-only comparison will always end with someone cheaper. If you want compounded medication, we do not offer it at any price, because the FDA's position on compounded copies is one we share. And if your insurance already covers an endocrinologist you trust, keep that appointment and spend your money elsewhere.
If instead you want a clinician who can tell you why the weight stopped moving and a fee that never rises when your dose does, the fit is real. The next step is the eligibility check, which asks about your history and your state and takes a few minutes. A clinician reviews every application and not everyone is accepted. If you cannot be accepted into care, you are never charged.
Frequently Asked Questions
Can I keep my own pharmacy?
Yes. Your clinician sends the prescription to the pharmacy you choose and that pharmacy bills you at its own price. We set nothing on the transaction and take nothing from it.
Is the medication included in the $299?
No. The fee covers the clinician relationship and the quarterly Biomarker Audit. Medication is billed separately by your pharmacy at pharmacy cost, with no markup or upcharge from us.
Why is $598 held on my card at sign-up?
The first charge covers your first two months of membership. It is held on your card at sign-up and charged only once a clinician accepts you into care. If you cannot be accepted, the hold is released and you are never charged. Once accepted, the first two months are charged and non-refundable.
What if my dose needs to go up or down?
Your fee does not change. There is no dose upcharge and no molecule upcharge, because the membership fee has no connection to your prescription. Your clinician adjusts the dose to the least medicine that gets you the most result.
Do I have to be on a GLP-1 to join?
No. Many members join for the clinical relationship and the quarterly labs, with or without medication. Whether a GLP-1 is clinically indicated is a decision your clinician makes after your history and your labs, never before.
How is this different from just using a telehealth prescriber?
A telehealth prescriber is paid for the prescription. Our clinicians are paid to know you, measure you every 90 days and follow the results over time. The prescription, when it is indicated, is one output of that relationship rather than the whole of it.
What happens to my membership if I stop losing weight?
Your clinician investigates rather than escalates. The quarterly audit shows whether the stall is insulin, thyroid, hormones or the drug itself and the protocol adjusts to the evidence. A plateau is a measurement problem before it is a dosing problem.
What the first 90 days actually look like
Because the two-month start is the part people hesitate over, the shape of the first quarter deserves its own description, told plainly and in order.
Week one is the eligibility check and the intake. The check asks about your state, your history and what you have already tried. If a clinician accepts you into care, the $598 hold is charged and the intake begins. The intake is a longer conversation than any appointment you have had through an insurer. It covers your medications, your family history, your sleep, your stress and what you want to be different a year from now. Nothing is prescribed during this conversation, because nothing should be prescribed before your labs are seen.
Week two or three is the first Biomarker Audit. You go to a Quest patient service center near you, the draw takes minutes and the panel comes back to your clinician as a cardiometabolic picture. It covers Hs-CRP, Lipoprotein (A), Hemoglobin A1c (HbA1c), Apolipoprotein B (ApoB), Fasting Insulin, TSH With Reflex To Free T4 and more.
Weeks three and four are the results conversation. Every number is explained in plain language and the protocol is built from what the panel actually says. If a medication is clinically indicated, it is prescribed here, to your pharmacy, at the pharmacy's own price. If the honest answer is that a prescription can wait, we say that too, because our revenue does not move either way.
Days 30 to 90 are the adjustment window. You message the care team as side effects or questions come up and the protocol adjusts to what you report. Some members need one adjustment in this window. Some need none. The cadence is the point: you are not waiting for a problem to become an appointment.
Day 90 is the second audit. The panel is drawn again and the trend line appears. The first panel is a photograph and the second is the beginning of a film and films are where guesswork ends. From here the membership runs on the rhythm it was built for: audit, adjust and measure again every 90 days, four times a year, for as long as you stay.
That is the whole shape. If it sounds slower than the app, it is, in the same way a diagnosis is slower than a guess. It is also the only version of this that can tell you why something is happening rather than selling you something in response to it.
One last thing
Before you decide anything, ask your current provider one question. Who is tracking my fasting insulin, my ApoB and my thyroid while I am on this drug? If there is no answer, the prescription has been flying without instruments. We would rather earn the $299 with the instruments on than sell you another vial in the dark.
Related Guides
- Cardiometabolic Optimization: the definitive guide
- What a Biomarker Audit includes
- Our GLP-1 pricing guide: Wegovy, Zepbound, Ozempic
- Who the membership is and is not for
References
- Direct Primary Care: Practice Distribution and Cost Across the Nation (J Am Board Fam Med). 2015. pubmed.ncbi.nlm.nih.gov/26546651/